EQS-News: Cannovum Cannabis AG
/ Key word(s): Corporate Action/Personnel
Cannovum Cannabis AG: Planned capital measures with reverse stock split and change in the supervisory board
The Supervisory Board of Cannovum Cannabis AG (stock exchanges Frankfurt, Xetra, Düsseldorf, Munich, Hamburg, Berlin, Tradegate, gettex: ISIN DE000A2LQU21) today approved the annual financial statements for the fiscal year 2022 (as prepared by the Management Board), the annual financial statements are thus adopted.
"Supervisory Board members Udo Schmickler, Niklas Kornder and Dr. Philipp Sewerin announced their resignation today. The Annual General Meeting on August 18, 2023 in Berlin will therefore elect new members to the Supervisory Board.
A proposal will also be made at this Annual General Meeting to reduce the Company's share capital by a ratio of 5:1 and to combine the shares accordingly by way of a reverse split. The percentage share in the Company attributable to each shareholder will not change as a result. However, the Company will again be in a position to raise new equity by issuing new shares above the calculated par value.
With its majority shareholding in Anbau-Allianz für Deutschland GmbH, Cannovum Cannabis AG is preparing for the upcoming legalization of cannabis for the pleasure market. Anbau-Allianz für Deutschland is the guarantor for pleasure cannabis in Germany. Founded by Cannovum Cannabis AG and the company Hortensien Spieker 2023, the Cultivation Alliance develops products for growers, club operators and ultimately end customers. It links investors with partners, supports research and development, and represents the interests of its members vis-à-vis politicians, the public, and authorities. The Anbau-Allianz combines presence, reach, brand profile, contacts to media, club operators and end customers, participation models and external experts with its members under one roof.
Contact: Klaus Madzia, IR & PR, Cannovum Cannabis AG. Phone +49 30 3982 163 62, klaus.madzia@cannovum.com
About Cannovum Cannabis AG: Cannovum Cannabis AG is the first German fully licensed cannabis company to be traded on the stock exchange. The shares are traded on the Frankfurt/Xetra, Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges. Cannovum Cannabis AG is ready for the legalization of cannabis and well-prepared.
28.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Cannovum Cannabis AG |
Rheinsberger Str. 76/77 | |
10115 Berlin | |
Germany | |
Phone: | +49 (0)30 3982 16360 |
E-mail: | klaus.madzia@cannovum.com |
Internet: | www.cannovum.com |
ISIN: | DE000A2LQU21 |
WKN: | A2LQU2 |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf (Primärmarkt), Frankfurt, Hamburg, Munich, Tradegate Exchange |
EQS News ID: | 1668221 |
End of News | EQS News Service |
|
1668221 28.06.2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.